English | 简体中文 | 繁體中文 | 한국어
Tuesday, 8 January 2013, 08:00 HKT
Share:

Source: INC Research, LLC
Jamie Macdonald Assumes CEO Role at INC Research; Succession Plan Complete

Raleigh, NC, Jan 8, 2013 - (ACN Newswire) - INC Research, LLC, a therapeutically focused clinical research organization (CRO) with a Trusted Process(R) for delivering reliable results, today reported the completion of its CEO succession plan announced in August 2012.

Effective Jan. 1, 2013, Jamie Macdonald, formerly Chief Operating Officer for the Company, officially assumed the role of INC Research's new Chief Executive Officer. Mr. Macdonald replaced James T. Ogle, who remains with the Company as Chairman of the Board. Alistair Macdonald, previously President, Clinical Development Services, assumed the role of Chief Operating Officer.

"With the completion of these changes and the additional executive appointments made in recent months, INC Research is strategically positioned for continued growth," said James Ogle, Chairman of the Board. "We greatly appreciate Jamie and Alistair's contributions to date and look forward to their future leadership as we continue to advance INC Research as a leading provider of clinical development solutions globally."

"I am excited about 2013 and the opportunities it holds for INC Research and our customers," noted Jamie Macdonald, Chief Executive Officer for the Company. "We will continue to leverage our enhanced global scale, renowned therapeutic capability and enhanced Trusted Process(R) to offer increasingly innovative clinical development solutions that improve efficiency and ultimately lead our customers to make better decisions faster. The future for our industry and our Company has never been brighter and we look forward to continuing to partner with our customers in the delivery of new medicines to market to improve world health."

About INC Research

INC Research is a therapeutically focused clinical research organization with a high-performance reputation for conducting global clinical developmentprograms of the highest integrity. Pharmaceutical and biotechnology companies look to INC Research for a complete range of customized Phase I through Phase IV programs in all therapeutic areas and innovative pediatric and women's health trials. The company's Trusted Process(R) methodology and therapeutic foresight lead customers to more confident, better-informed drug and device development decisions. INC Research is headquartered in Raleigh, NC. For more information, please visit www.incresearch.com or follow us at @inc_research.

Contact: Lori Dorer, Media +1-513-345-1685


This announcement is distributed by Thomson Reuters on behalf of Thomson Reuters clients.

The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and other applicable laws; and
(ii) they are solely responsible for the content, accuracy and originality of the information contained therein.

Source: INC RESEARCH, LLC via Thomson Reuters ONE

Topic: Press release summary

http://www.acnnewswire.com
From the Asia Corporate News Network


Copyright © 2014 ACN Newswire. All rights reserved. A division of Asia Corporate News Network.

 ACN Search:
 
INC Research, LLC
Apr 23, 2014 01:40 HKT
INC Research, LLC First Quarter 2014 Results of Operations Release Date and Conference Call
Mar 28, 2014 06:30 HKT
INC Research CEO to Represent CRO Industry on Avoca Panel at Partnerships in Clinical Trials
Mar 7, 2014 07:30 HKT
INC Research Further Expands Geographic Footprint with Acquisition of Leading Middle Eastern CRO MEK Consulting
Feb 25, 2014 06:05 HKT
INC Research Appoints 30-Year Industry Veteran Jane Winter to Lead Global Consulting Practice
Feb 7, 2014 08:15 HKT
INC Research Expands Clinical Pharmacology Team to Support Early Phase Business Unit
Jan 18, 2014 04:05 HKT
INC Research Strengthens Oncology Team with Two Key Appointments
Dec 17, 2013 08:30 HKT
INC Research Reinforces Japan Presence with Key Leadership Appointments
Nov 18, 2013 23:10 HKT
INC Research Appoints Gregory M. Hockel, PhD to Lead Regulatory Consulting Practice
Nov 12, 2013 22:20 HKT
INC Research Further Demonstrates Commitment to Drug Development Communities through Unveiling of New Brand Campaign
Oct 15, 2013 06:30 HKT
INC Research Strengthens Cardiovascular Research Capabilities with Appointment of Dr. Martin Sullivan as Executive Medical Director, Cardiovascular Medicine
More news >>
 News Alerts »
Copyright © 2014 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Privacy Policy | Terms of Use | RSS
US: +1 800 291 0906 | Beijing: +86 10 8405 3688 | Hong Kong: +852 2217 2912 | Singapore: +65 6304 8926 | Tokyo: +81 3 5791 1818

Connect With us: